Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia

Clinical trial NCT01912560 · COMPLETED

Trial details

NCT number: NCT01912560
Sponsor: Catabasis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemia Hypercholesterolemia Hypertriglyceridemia

Start date: 2013-07-01
Primary completion: 2013-12-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.